Hermida shares that emerging research suggests GLP-1 medications could have effects beyond obesity and diabetes. A short post with few specifics.
Recap by typeshit. Post by Alvaro Hermida on X.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
Moss says he once believed GLP-1s caused far more muscle loss than ordinary calorie cutting. He now says he got that wrong.
Topol points to neoantigens, the proteins or peptides on cancer cell surfaces, as the base of personalized cancer therapies.
He points to dry mouth, reflux and diet shifts as oral health risks, with screening questions and sedation considerations for dental teams.
Australian experts note about half a million people there use GLP-1 drugs for diabetes alone, and lay out what new users should keep in mind about nutrition.
Loading…